Clinical Trial: Adaptive Radiation for Abdominopelvic Metastases
Study Status: Completed
Recruit Status: RECRUITING
Condition: Neoplasm - Soft Tissue Pelvis Malignant Secondary
Study Type: INTERVENTIONAL
Official Title: Adaptive Radiation for Abdominopelvic Metastases (ARAM)
Brief Summary:
Single arm Phase I trial of adaptive stereotactic body radiation (SBRT) for abdominopelvic metastases.Adaptive SBRT will allow for escalation of the prescription dose and target coverage while maintaining grade 3+ toxicity no greater than 10%.Subjects with metastatic cancer to the abdomen or pelvis requiring local control or palliation will be enrolled.
Read more